Basic/Clinical Science Session
Emerging Therapeutic Approaches in AKI: New Targets and How to Reach Them
November 04, 2022 | 02:00 PM - 04:00 PM
Location: W308, Orange County Convention Center, West Building
Session Description
Despite advances in clinical care and understanding of the underlying pathophysiology, treatment for AKI remains a major unmet medical need. This session describes how novel therapeutic targets and nanoparticle-based strategies may change future AKI therapeutics.
Learning Objective(s)
- Describe the use of senolytic therapy to promote kidney repair
- Evaluate the use of mitochondrial therapy for kidney injury
- Discuss the application of nanotherapeutics in kidney biology
- Examine the clinical potential of nanoparticles in AKI therapeutics
Learning Pathway(s)
- AKI and Critical Care
Moderators
- Monica Chang Panesso, MD
- Prabhleen Singh, MD, MPH
Presentations
- Senolytic Treatment to Promote Kidney Repair
02:00 PM - 02:30 PM
David A. Ferenbach, MD, PhD
- Mitochondrial Therapy for AKI
02:30 PM - 03:00 PM
Amandeep Bajwa, PhD
- Nanotherapeutics in Kidney Biology
03:00 PM - 03:30 PM
Eun ji Chung, PhD
- Clinical Potential of Nanoparticles in AKI
03:30 PM - 04:00 PM
Daniel A. Heller, PhD
